EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reduction in Donor‐Derived Cell‐Free DNA After Rejection Treatment is Associated With Improved Long Term Allograft Function

Lauren Schumacher iD, Olivia Philippart iD, Jesica Yau iD, Fawad Shuaib, Sravanthi Paluri, Ana Lia Castellanos, Aric Schadler iD, Hasan Fattah

Clinical Transplantation · 2026-06 · 40 (6)

DOI: 10.1111/ctr.70603 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, online erschienen am 23.06.2026. Verfasst von Lauren Schumacher und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Kentucky Healthcare, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: Graft Rejection, Cell-Free Nucleic Acids, Kidney Transplantation, Biomarkers. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Donor derived cell‐free DNA (dd‐cfDNA) has become a useful biomarker for monitoring of kidney transplant rejection, however utilization after rejection is not well established. We conducted a retrospective cohort study of 64 kidney transplant recipients (KTRs) with biopsy‐proven rejection and concomitant dd‐cfDNA monitoring. The primary outcome was to examine the relationship between changes in dd‐cfDNA and allograft function after rejection. Secondary outcomes included the effect of a ≥61% dd‐cfDNA reduction on eGFR and proteinuria, and impact of persistently elevated dd‐cfDNA. The percent change in dd‐cfDNA from rejection to 6 months post‐rejection and 1‐year post‐rejection was negatively correlated with eGFR change at 1, 2, and 3 years. No correlation was seen with dd‐cfDNA values at 1 month. KTRs with at least 61% decrease in dd‐cfDNA from rejection to 1‐year post‐rejection showed improvement in eGFR at 1, 2, and 3 years. KTRs with persistently elevated dd‐cfDNA showed significantly worse change in eGFR to all time points compared to those without. Incidence of proteinuria at 1, 2, and 3 years trended lower in KTRs with ≥61% decrease in dd‐cfDNA. dd‐cfDNA was negatively correlated with eGFR, primarily at 6–12 months post‐rejection. In conclusion, persistently elevated dd‐cfDNA correlates with worse longitudinal changes in eGFR through 3 years post‐rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionCell-Free Nucleic AcidsKidney TransplantationBiomarkersTissue DonorsKidney Failure, ChronicPostoperative ComplicationsHumansFemaleRetrospective StudiesGlomerular Filtration RateMaleFollow-Up StudiesPrognosisKidney Function TestsGraft SurvivalMiddle AgedRisk FactorsAdultAllografts

Stichwörter der Autor:innen

biomarkerbiopsydonor‐derived cell‐free DNAgraft rejectionkidney transplantationrejection

Substanzen

Cell-Free Nucleic AcidsBiomarkers

Autor:innen und Institutionen

  • Department of Pharmacy, University of Kentucky Healthcare, Lexington, Kentucky, USA.
  • CareDx, Brisbane, California, USA.
  • Division of Transplant, Department of Nephrology, University of Kentucky Healthcare, Lexington, Kentucky, USA.
  • College of Pharmacy, University of Kentucky, Lexington, Kentucky, USA.

ORCID-Profile: Lauren Schumacher, Olivia Philippart, Jesica Yau, Aric Schadler

Förderung

  • NIH National Center for Advancing Translational Sciences

Zitieren

APA

Schumacher, L., Philippart, O., Yau, J., Shuaib, F., Paluri, S., Castellanos, A. L., Schadler, A., & Fattah, H. (2026). Reduction in Donor‐Derived Cell‐Free DNA After Rejection Treatment is Associated With Improved Long Term Allograft Function. Clinical Transplantation, 40(6). https://doi.org/10.1111/ctr.70603

Vancouver

Schumacher L, Philippart O, Yau J, Shuaib F, Paluri S, Castellanos AL, et al. Reduction in Donor‐Derived Cell‐Free DNA After Rejection Treatment is Associated With Improved Long Term Allograft Function. Clinical Transplantation. 2026;40(6). doi:10.1111/ctr.70603

BibTeX
@article{Schumacher2026,
  author = {Schumacher, Lauren and Philippart, Olivia and Yau, Jesica and Shuaib, Fawad and Paluri, Sravanthi and Castellanos, Ana Lia and Schadler, Aric and Fattah, Hasan},
  title = {Reduction in Donor‐Derived Cell‐Free DNA After Rejection Treatment is Associated With Improved Long Term Allograft Function},
  journal = {Clinical Transplantation},
  year = {2026},
  volume = {40},
  number = {6},
  doi = {10.1111/ctr.70603}
}
Kostenlos starten →